Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Open Monoclonal Technology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Open Monoclonal Technology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Open Monoclonal Technology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Open Monoclonal Technology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Open Monoclonal Technology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Open Monoclonal Technology Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Symphogen Enters Into Agreement With Open Monoclonal Technology 11
Open Monoclonal Technology Enters Into Agreement With CNA Development For OmniRat Antibody 12
Open Monoclonal Expands Agreement with CNA Development 13
Crystal Biosciences Enters Into Agreement With Open Monoclonal Technology For Gel-Encapsulated Microenvironment Technology 14
Single Cell Technology Enters Into Co-Development Agreement With Open Monoclonal Technology 15
Trellis Bioscience Enters Into Agreement With Open Monoclonal Technology To Discover Human Therapeutic Antibodies 16
WuXi PharmaTech Expands Agreement with Open Monoclonal Technology 17
Open Monoclonal Technology Enters Into Antibody Discovery Agreement With Merck 18
EMD Serono And Open Monoclonal Technology Expand Discovery Agreement For OmniRat 19
Licensing Agreements 20
ARMO BioSciences Enters into Licensing Agreement with Open Monoclonal 20
Open Monoclonal Enters into Licensing Agreement with University of Nottingham 21
Open Monoclonal Enters into Licensing Agreement with Celgene 22
Pfizer Enters into Licensing Agreement with Open Monoclonal Technology 23
Seattle Genetics Enters into Licensing Agreement with Open Monoclonal Technology 24
Five Prime Therapeutics Enters into Licensing Agreement with Open Monoclonal 25
Open Monoclonal Enters into Licensing Agreement with Amgen 26
HanAll BioPharma Enters into Licensing Agreement with Open Monoclonal 27
Open Monoclonal Technology Enters into Licensing Agreement with Genmab for OmniRat, OmniMouse and OmniFlic 28
Acquisition 29
Ligand Pharma Acquires Open Monoclonal Technology for USD178 Million 29
Genentech And F. Hoffmann-La Roche To Acquire Open Monoclonal Technology’s Spin-Out Companies 30
Open Monoclonal Technology Inc – Key Competitors 31
Open Monoclonal Technology Inc – Key Employees 32
Open Monoclonal Technology Inc – Locations And Subsidiaries 33
Head Office 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34
Open Monoclonal Technology Inc, Pharmaceuticals & Healthcare, Key Facts 2
Open Monoclonal Technology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Open Monoclonal Technology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Open Monoclonal Technology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Open Monoclonal Technology Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Open Monoclonal Technology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Symphogen Enters Into Agreement With Open Monoclonal Technology 11
Open Monoclonal Technology Enters Into Agreement With CNA Development For OmniRat Antibody 12
Open Monoclonal Expands Agreement with CNA Development 13
Crystal Biosciences Enters Into Agreement With Open Monoclonal Technology For Gel-Encapsulated Microenvironment Technology 14
Single Cell Technology Enters Into Co-Development Agreement With Open Monoclonal Technology 15
Trellis Bioscience Enters Into Agreement With Open Monoclonal Technology To Discover Human Therapeutic Antibodies 16
WuXi PharmaTech Expands Agreement with Open Monoclonal Technology 17
Open Monoclonal Technology Enters Into Antibody Discovery Agreement With Merck 18
EMD Serono And Open Monoclonal Technology Expand Discovery Agreement For OmniRat 19
ARMO BioSciences Enters into Licensing Agreement with Open Monoclonal 20
Open Monoclonal Enters into Licensing Agreement with University of Nottingham 21
Open Monoclonal Enters into Licensing Agreement with Celgene 22
Pfizer Enters into Licensing Agreement with Open Monoclonal Technology 23
Seattle Genetics Enters into Licensing Agreement with Open Monoclonal Technology 24
Five Prime Therapeutics Enters into Licensing Agreement with Open Monoclonal 25
Open Monoclonal Enters into Licensing Agreement with Amgen 26
HanAll BioPharma Enters into Licensing Agreement with Open Monoclonal 27
Open Monoclonal Technology Enters into Licensing Agreement with Genmab for OmniRat, OmniMouse and OmniFlic 28
Ligand Pharma Acquires Open Monoclonal Technology for USD178 Million 29
Genentech And F. Hoffmann-La Roche To Acquire Open Monoclonal Technology's Spin-Out Companies 30
Open Monoclonal Technology Inc, Key Competitors 31
Open Monoclonal Technology Inc, Key Employees 32
List of Figures
Open Monoclonal Technology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Open Monoclonal Technology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Open Monoclonal Technology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Open Monoclonal Technology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Open Monoclonal Technology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Open Monoclonal Technology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Open Monoclonal Technology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Open Monoclonal Technology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8